Lidocaine Hci Injection, Solution
Product Images NDC 51662-1364

8 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lidocaine Hci (NDC 51662-1364). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of lidocaine hydrochloride (LIDOCAINE HCI) showing the molecular arrangement of atoms including aromatic ring, amide bonds, and hydrochloride group.*
FDA Label Image
FDA Label Image

Ial Label (Vial Label)

Ial Label (Vial Label)
Label for Lidocaine HCl Injection, USP 2% (20 mg/mL) solution for intravenous use in a 5 mL single-dose vial. The label states the product is sterile, nonpyrogenic, preservative-free, and intended for cardiac arrhythmias. It includes dosage information, storage instructions, the labeler HF Acquisition Co LLC DBA HealthFirst, and an NDC of 63323-208-05 with barcode.*
FDA Label Image

Serialized Labeling (Serialized Labeling)

Serialized Labeling (Serialized Labeling)
LIDOCAINE HCI injection, USP 2% (20 mg/mL) in a 5 mL single-dose vial. The label shows the drug is for intravenous use and distributed by HF Acquisition Co LLC, Mukilteo, WA. The vial is clear with a gray cap and has a barcode label.*
FDA Label Image

Pouch Labeling (51662 1364 2 Pouch)

Pouch Labeling (51662 1364 2 Pouch)
Label for Lidocaine HCl Injection, USP 2% (20 mg/mL) in a 5 mL vial. The label shows the NDC number 51662-1364-2, lot number 123456, and expiration date 2030-01-01. It is manufactured by HF Acquisition Co LLC, DBA HealthFirst. The label also notes the intravenous use and sterile, preservative-free solution characteristics.*
FDA Label Image

Vial Label (51662 1364 2 Vial)

Vial Label (51662 1364 2 Vial)
Label for LIDOCAINE HCI Injection, USP 2% (20 mg per mL), 5 mL single dose vial. Indicates intravenous use for cardiac arrhythmias, sterile nonpyrogenic, preservative free. Manufactured by Fresenius Kabi, Lake Zurich, IL. Includes instructions for storage and dosage, barcode, and lot/expiration information.*
FDA Label Image

Case Labeling (51662 1364 3 Case)

Case Labeling (51662 1364 3 Case)
Label for LIDOCAINE HCI Injection USP 2%, 20 mg/mL injection solution in a 5 mL vial, case of 25. The label includes the NDC 51662-1364-3, lot number 123456, and expiration date 2030-01-01. Manufacturer is HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. The label describes the product as sterile, nonpyrogenic, preservative-free, for intravenous use.*
FDA Label Image

Rfid Label (51662 1364 3 Rfid)

Rfid Label (51662 1364 3 Rfid)
A white rectangular label on a clear pouch with black printed text and a barcode. The label includes GS1 formatted barcodes and identifiers, showing a unique serialized code and batch number. It mentions the distributor HF Acquisitions Co., LLC, Mukilteo, WA, and directs users to see the manufacturer's insert for more information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.